• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从精神病学角度看,阿育吠陀是如何起作用的?致幻治疗的优缺点。

How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy.

机构信息

Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield, UK.

Department of Clinical Neurosciences/DIMSC, School of Medicine, Section of Psychiatry, Polytechnic University of Marche, Ancona, Italy.

出版信息

Hum Psychopharmacol. 2020 May;35(3):e2728. doi: 10.1002/hup.2728. Epub 2020 Mar 27.

DOI:10.1002/hup.2728
PMID:32220028
Abstract

OBJECTIVE

Ayahuasca is a hallucinogenic plant preparation, traditionally consumed in sacred ceremonies by indigenous North-Westerner Amazonian countries like Colombia, Peru, Brazil, and Ecuador. It is fundamental to carefully balance benefits/risks related to the ayahuasca intake, both during ceremonies and experimental settings. The aim is at evaluating and comparing the potential therapeutic benefits versus health risks related to ayahuasca intake (both acutely and chronically), focusing on its application in psychedelic psychiatry.

DESIGN

A comprehensive mini overview focusing on psychiatric outcomes following ayahuasca intake both in healthy volunteers and in clinical samples.

RESULTS

Preclinical, observational, and experimental studies in healthy volunteers as well as in clinical samples suggest that ayahuasca may be beneficial as an antidepressant, emotional regulator, anxiolytic, and antiaddictive drug, by exerting fast-acting and enduring clinical effects. Ayahuasca appears to be safe and well tolerated, nausea and emesis being the most reported and transient side effects. Some findings suggest not to use ayahuasca in bipolar or psychotic patients because of an increased risk of manic switch and/or psychotic onset.

CONCLUSIONS

Further research should be carried out in randomized, double-blind, placebo-controlled trials, by implementing neuroimaging studies, in order to better evaluate therapeutic potential of ayahuasca in mental disorders.

摘要

目的

阿育吠陀是一种致幻植物制剂,传统上由哥伦比亚、秘鲁、巴西和厄瓜多尔等北美西部亚马逊国家在神圣仪式中使用。在仪式和实验环境中,谨慎平衡与阿育吠陀摄入相关的益处/风险至关重要。目的是评估和比较与阿育吠陀摄入(急性和慢性)相关的潜在治疗益处与健康风险,重点关注其在迷幻精神病学中的应用。

设计

全面的小型综述,重点关注阿育吠陀摄入后对健康志愿者和临床样本的精神科结果。

结果

在健康志愿者和临床样本中的临床前、观察性和实验研究表明,阿育吠陀可能作为抗抑郁药、情绪调节剂、抗焦虑药和抗成瘾药物有益,因为它具有快速作用和持久的临床效果。阿育吠陀似乎是安全且耐受良好的,最常见且短暂的副作用是恶心和呕吐。一些研究结果表明,由于躁狂发作的风险增加,不应该在双相情感障碍或精神病患者中使用阿育吠陀。

结论

应该在随机、双盲、安慰剂对照试验中进行进一步研究,通过实施神经影像学研究,以更好地评估阿育吠陀在精神障碍中的治疗潜力。

相似文献

1
How does ayahuasca work from a psychiatric perspective? Pros and cons of the entheogenic therapy.从精神病学角度看,阿育吠陀是如何起作用的?致幻治疗的优缺点。
Hum Psychopharmacol. 2020 May;35(3):e2728. doi: 10.1002/hup.2728. Epub 2020 Mar 27.
2
Antidepressant Effects of a Single Dose of Ayahuasca in Patients With Recurrent Depression: A SPECT Study.单剂量死藤水对复发性抑郁症患者的抗抑郁作用:一项单光子发射计算机断层扫描研究
J Clin Psychopharmacol. 2016 Feb;36(1):77-81. doi: 10.1097/JCP.0000000000000436.
3
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial.致幻剂依卡叶碱治疗难治性抑郁症的快速抗抑郁作用:一项随机安慰剂对照试验。
Psychol Med. 2019 Mar;49(4):655-663. doi: 10.1017/S0033291718001356. Epub 2018 Jun 15.
4
Molecular Pathways of the Therapeutic Effects of Ayahuasca, a Botanical Psychedelic and Potential Rapid-Acting Antidepressant.植物致幻剂亚甲二氧基甲基苯丙胺( ayahuasca )的治疗作用的分子途径,一种潜在的快速抗抑郁药。
Biomolecules. 2022 Nov 2;12(11):1618. doi: 10.3390/biom12111618.
5
Ayahuasca Exposure: Descriptive Analysis of Calls to US Poison Control Centers from 2005 to 2015.阿亚瓦西卡暴露情况:2005年至2015年美国中毒控制中心接到的相关电话描述性分析
J Med Toxicol. 2017 Sep;13(3):245-248. doi: 10.1007/s13181-016-0593-1. Epub 2016 Nov 28.
6
Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report.单次服用阿育吠陀在复发性抑郁症患者中的抗抑郁作用:初步报告。
Braz J Psychiatry. 2015 Jan-Mar;37(1):13-20. doi: 10.1590/1516-4446-2014-1496.
7
Ayahuasca, a potentially rapid acting antidepressant: focus on safety and tolerability.致幻剂,一种具有潜在快速抗抑郁作用的药物:重点关注安全性和耐受性。
Expert Opin Drug Saf. 2022 Jun;21(6):789-801. doi: 10.1080/14740338.2022.2054988. Epub 2022 Mar 23.
8
The current state of research on ayahuasca: A systematic review of human studies assessing psychiatric symptoms, neuropsychological functioning, and neuroimaging.死藤水的研究现状:对评估精神症状、神经心理功能和神经影像学的人体研究的系统评价
J Psychopharmacol. 2016 Dec;30(12):1230-1247. doi: 10.1177/0269881116652578. Epub 2016 Jun 10.
9
Psychedelic Therapy: A Primer for Primary Care Clinicians-N,N-Dimethyltryptamine and Ayahuasca.迷幻疗法:初级保健临床医生指南-N,N-二甲基色胺和瓜拉那。
Am J Ther. 2024;31(2):e112-e120. doi: 10.1097/MJT.0000000000001725.
10
A placebo-controlled study of the effects of ayahuasca, set and setting on mental health of participants in ayahuasca group retreats.安慰剂对照研究的影响,设置和设置对心理健康的参与者在圣佩德罗团体撤退。
Psychopharmacology (Berl). 2021 Jul;238(7):1899-1910. doi: 10.1007/s00213-021-05817-8. Epub 2021 Mar 10.

引用本文的文献

1
Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.迷幻辅助疗法:心理健康治疗中的潜在益处与挑战
Med Sci Monit. 2025 Aug 9;31:e948302. doi: 10.12659/MSM.948302.
2
Treatment of depressive and negative symptoms in individuals with schizoaffective disorders using serotoninergic psychedelics: a case report.使用血清素能致幻剂治疗分裂情感性障碍患者的抑郁和阴性症状:一例报告
J Psychiatry Neurosci. 2025 Jul 25;50(4):E234-E236. doi: 10.1503/jpn.250005. Print 2025 Jul-Aug.
3
Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.
重新审视致幻剂诱发精神病的证据:综述概述、系统评价及人类研究的荟萃分析
Mol Psychiatry. 2025 Mar;30(3):1223-1255. doi: 10.1038/s41380-024-02800-5. Epub 2024 Nov 27.
4
Ayahuasca and its interaction with the sigma-1 receptor: a potential treatment for COVID-19.阿亚瓦斯卡及其与西格玛-1受体的相互作用:一种治疗COVID-19的潜在方法。
Braz J Psychiatry. 2022 Jul 26;44(4):465-6. doi: 10.47626/1516-4446-2022-2541.
5
N,N-dimethyltryptamine and Amazonian ayahuasca plant medicine.N,N-二甲基色胺与亚马孙地区的苦艾草植物药。
Hum Psychopharmacol. 2022 May;37(3):e2835. doi: 10.1002/hup.2835. Epub 2022 Feb 17.
6
Influence of Context and Setting on the Mental Health and Wellbeing Outcomes of Ayahuasca Drinkers: Results of a Large International Survey.情境与环境对死藤水饮用者心理健康及幸福感结果的影响:一项大型国际调查的结果
Front Pharmacol. 2021 Apr 21;12:623979. doi: 10.3389/fphar.2021.623979. eCollection 2021.
7
Fast Hollow Fiber Liquid-Phase Microextraction as a Greener Alternative for the Determination of N,N-Dimethyltryptamine and Harmala Alkaloids in Human Urine.快速中空纤维液相微萃取作为一种更绿色的替代方法用于测定人尿中的N,N-二甲基色胺和哈尔满生物碱。
Front Chem. 2020 Oct 7;8:558501. doi: 10.3389/fchem.2020.558501. eCollection 2020.